SYNEOS HEALTH

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark SYNEOS HEALTH was filed as Word mark on 06/03/2021 at the World Intellectual Property Organization.

Trademark Details Last update: May 29, 2023

Trademark form Word mark
File reference 1617942
Countries Australia Brazil Canada Switzerland Colombia em United Kingdom Indonesia Israel India Japan South Korea Mexico Malaysia New Zealand Philippines Russia Singapore Thailand Turkey Ukraine Vietnam
Base trademark US No. 90702195, May 11, 2021
Application date June 3, 2021
Expiration date June 3, 2031

Trademark owner

1030 Sync Street
Morrisville NC 27560
US

Trademark representatives

P.O. Box 64807 Chicago IL 60664-0807 US

goods and services

35 Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; providing business assistance to pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
41 Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and production of podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and production of podcasts
42 Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information
44 Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications

Trademark history

Date Document number Area Entry
May 10, 2023 2023/21 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 14, 2023 2023/15 Gaz PH RAW: Rule 18ter(2)(i) GP following a provisional refusal
April 3, 2023 2023/14 Gaz MY Rejection
March 16, 2023 2023/11 Gaz TH Rejection
January 19, 2023 2023/3 Gaz CA Rejection
December 15, 2022 2022/51 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 25, 2022 2022/43 Gaz KR Rejection
October 4, 2022 2022/40 Gaz VN Rejection
September 23, 2022 2022/39 Gaz ID Rejection
September 7, 2022 2022/37 Gaz BR Rejection
August 29, 2022 2022/35 Gaz IN Rejection
August 12, 2022 2022/33 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 12, 2022 2022/33 Gaz CH Rejection
August 5, 2022 2022/31 Gaz MX Rejection
July 21, 2022 2022/29 Gaz JP Rejection
July 14, 2022 2022/28 Gaz CO Rejection
July 6, 2022 2022/27 Gaz UA Rejection
May 2, 2022 2022/19 Gaz IL Rejection
March 25, 2022 2022/13 Gaz NZ Rejection
March 1, 2022 2022/10 Gaz SG Rejection
February 28, 2022 2022/9 Gaz TR Rejection
February 24, 2022 2022/8 Gaz EM Rejection
January 31, 2022 2022/5 Gaz RU Rejection
January 26, 2022 2022/4 Gaz GB Rejection
January 5, 2022 2022/1 Gaz AU Rejection
December 19, 2021 2022/2 Gaz PH Rejection
June 3, 2021 2021/38 Gaz US Registration

ID: 141617942